Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases

Clinical trial NCT00501605 · COMPLETED

Trial details

NCT number: NCT00501605
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Liver Metastases

Start date: 2003-02-01
Primary completion: 2005-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.